Details for 2016734013

Up to date per 04.04.2026

Actions

Title / Product Name

CHECKPOINT-INHIBITOR UND GANZZELLIGES MYCOBAKTERIUM ZUR VERWENDUNG IN DER KREBSTHERAPIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016734013

EP Publication Number

3319635

E-Number

1383938

Language

PCT Number

GB16051893

Publication Date

16.05.2018 A

21.04.2021 B1

Registration Date

21.04.2021

AT Publication Date

15.05.2021

Application Date

24.06.2016

Registration Number

Priorities

24.06.2015

201511120

24.06.2015

201511121

IPC

A61K 39/395 20060101AFI20170110BHEP

Maximum Duration of Protection

24.06.2036

Owner

Immodulon Therapeutics Limited6-9 The Square Stockley Park Uxbridge UB11 1FWGB

Representative

Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT

Inventor

AKLE, CharlesImmodulon Therapeutics Limited 6-9 The Square Stockley Park Uxbridge UB11 1FWGB

BRUNET, Laura RosaImmodulon Therapeutics Limited 6-9 The Square Stockley Park Uxbridge UB11 1FWGB

Information about Fees